Is PALB2 p.Lys7= (c.21G>A) pathogenic?

PALB2 p.Lys7= (c.21G>A) is classified Benign/Likely benign in PALB2 (ClinVar, Multiple submitters, 6 submitters; last evaluated 2025-10-23). Very rare (popmax 0.0011%, sas); Associated with hereditary neoplastic syndrome.

What condition is associated with PALB2 p.Lys7= (c.21G>A)?

PALB2 p.Lys7= (c.21G>A) is associated with hereditary neoplastic syndrome, breast cancer, hereditary breast carcinoma (ClinVar).

How common is PALB2 p.Lys7= (c.21G>A) in the general population?

PALB2 p.Lys7= (c.21G>A) is very rare (popmax 0.0011%, sas) (gnomAD).

PALB2 p.Lys7=

c.21G>A · rs1424944402 · VCV480284

Benign/Likely benign Multiple submitters

Classification

Benign/Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 6 submitters

gnomAD v4.1

Rare

very rare (popmax 0.0011%, sas)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -0.38	GERP 1.7, phastCons 0.082
Overall
CADD	11.37	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0011% South Asian · 1/90,966 alleles

Filtering AF 7.9e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.4e-05%

Overall 0.00031% 5/1,613,366 alleles · very rare

Ancestry group	Frequency	1 in
South Asiangrpmax	0.0011%	90,966
European (non-Finnish)	0.000339%	294,971

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: PALB2
Protein: p.Lys7=
Coding: c.21G>A
MANE Select: NM_024675
dbSNP: rs1424944402
Type: single nucleotide variant
Location: chr16:23641137 (GRCh38)
Gene constraint: LOEUF 0.9 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 54.07 · 4 PDB
Residue 7: the 'interaction with rad51' region; the 'required for its oligomerization and is important for its focal concentration at dna damage sites' region; the 'dna-binding (with the preference d loop > dsdna > ssdna)' region; the 'interaction with brca1' region

Full PALB2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: breast cancer hereditary breast carcinoma

Similar variants

PALB2 p.Lys7Arg Conflicting classifications of pathogenicity ★ ⚠ same residue
PALB2 p.Lys7Asn Uncertain significance ★ ⚠ same residue
PALB2 p.Lys7Met Uncertain significance ★ ⚠ same residue
PALB2 p.Lys7fs Likely pathogenic ★ same residue
PALB2 c.3350+4A>G Likely pathogenic ★★★ same condition
PALB2 p.Arg1117Lys Pathogenic ★★★ ⚠ same condition
PALB2 p.Gln228Ter Pathogenic ★★★ same condition
PALB2 p.Gln692Ter Likely pathogenic ★★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/palb2-p-lys7 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown